EBI-013

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEBI-013
Drug Alias Namemuscle wasting protein therapeutics (Eleven Biotherapeutics)myostatin modulator (Eleven Biotherapeutics)EBI-013
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsMuscular Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSesen Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSesen Bio Inc
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy

Other Information

ATC CodeN/A
Related LinksN/A